This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Health Park Co., Ltd.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations by Inventor Hui Jin
Introduction
Hui Jin is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative solutions for preventing and treating diseases.
Latest Patents
Hui Jin holds a patent for "Virus-like particles co-expressing IMC, ROP18, and MIC8, and pharmaceutical composition comprising the same." This invention relates to a virus-like particle designed to prevent or treat toxoplasmosis. It comprises influenza virus matrix protein 1 and surface antigen proteins, including an inner membrane complex, Rhoptry protein 18, and Microneme protein 8. This innovative approach has the potential to enhance therapeutic options for patients suffering from this disease.
Career Highlights
Hui Jin is currently associated with Health Park Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving health outcomes through innovative pharmaceutical solutions.
Collaborations
Hui Jin collaborates with talented individuals in his field, including Hyunwoo Park and Fu Shi Quan. These partnerships enhance the scope and impact of his research endeavors.
Conclusion
Hui Jin's contributions to the field of pharmaceuticals, particularly through his innovative patent, demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the treatment of toxoplasmosis and improve patient care.